Atherectomy Devices Market Size & Growth Forecast 2026–2035, By Segments (Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Atherectomy Devices Market size was more than USD 1.08 Billion in 2025 and is set to grow at a 8.1% CAGR between 2026 and 2035, crossing USD 2.35 Billion by 2035. The industry revenue for 2026 is estimated at USD 1.16 billion.

• Base Year Value (2025): USD 1.08 Billion
• CAGR (2026-2035): 8.1%
• Forecast Year Value (2035): USD 2.35 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Atherectomy Devices Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America accounted for 43.99% of the market in 2025, driven by mature cardiovascular care networks, high procedure volumes, and widespread clinician adoption for complex lesion preparation.
  • Asia Pacific is forecast to expand at a 9.15% CAGR as access to minimally invasive vascular procedures improves and healthcare providers broaden capabilities for managing complex arterial blockages.

• Segment Momentum:

  • Directional Atherectomy held a 38.05% share in 2025 because it provides controlled plaque removal and fits established treatment workflows for complex peripheral lesions requiring precise vessel preparation.
  • Laser Atherectomy is the fastest-growing type as clinicians increasingly adopt it for managing complex calcified, fibrotic, and in-stent lesions that require greater procedural flexibility.

• Market Expansion Drivers:

  • Rising prevalence of coronary and peripheral artery diseases driving procedural demand.
  • Increasing adoption of minimally invasive vascular procedures improving clinical outcomes.
  • Expansion of hybrid cath labs enabling advanced image-guided cardiovascular interventions.

• Leading Market Participants:

  Top companies in the atherectomy devices market include Boston Scientific Corporation (United States), Medtronic plc (Ireland), Abbott Laboratories (United States), Koninklijke Philips N.V. (Netherlands), Becton Dickinson and Company (United States), Terumo Corporation (Japan), AngioDynamics Inc. (United States), Cardinal Health Inc. (United States), Avinger Inc. (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 1.08 Billion
  • Projected Market Size: USD 2.35 Billion by 2035
  • Growth Forecasts: 8.1% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Directional Atherectomy (Type)
  • Emerging Opportunity Segment: Laser Atherectomy (Type)

Market Growth Drivers and Industry Trends

Rising prevalence of coronary and peripheral artery diseases driving procedural demand

A growing patient pool with calcified, complex, and diffusely narrowed vessels is directly increasing intervention volumes, which is driving demand for the atherectomy devices market. In clinical practice, coronary artery disease and peripheral artery disease often present with lesions that are difficult to treat effectively with balloon angioplasty alone, prompting physicians to use atherectomy to modify plaque before stenting or other endovascular steps. This transitions purchasing toward devices that can improve lesion preparation, support procedural success in challenging anatomy, and help interventional teams manage cases that would otherwise face higher rates of incomplete dilation or downstream complications.

Increasing adoption of minimally invasive vascular procedures improving clinical outcomes

The shift toward catheter-based treatment is driving market development for the atherectomy devices market as providers prioritize therapies that shorten hospital stays, reduce recovery time, and expand treatment eligibility for older and higher-risk patients. Atherectomy fits this care model by allowing targeted plaque removal through percutaneous access, which aligns with physician preference for less invasive workflows and hospital efforts to move more vascular interventions into efficient procedural settings. As minimally invasive care becomes the standard approach for many coronary and peripheral interventions, device selection increasingly favors technologies that can improve vessel preparation and support better immediate procedural results.

Expansion of hybrid cath labs enabling advanced image-guided cardiovascular interventions

Investment in hybrid cath labs is encouraging market growth for the atherectomy devices market by giving clinicians the infrastructure needed to perform more complex image-guided vascular procedures in a single integrated setting. These labs combine high-quality imaging, interventional equipment, and surgical backup, which makes operators more willing to treat heavily calcified or anatomically challenging lesions that benefit from atherectomy. In practice, this raises utilization by improving procedural confidence, enabling better visualization during plaque modification, and allowing hospitals to broaden the range of cardiovascular interventions they can manage without referring difficult cases elsewhere.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of PAD (Peripheral Artery Disease)	3.10%	Short term (≤ 2 yrs)	North America, Europe (spillover: Asia Pacific)	High	Fast
Increasing adoption of minimally invasive atherectomy	2.90%	Medium term (2–5 yrs)	Asia Pacific, North America (spillover: Europe)	Medium	Moderate
Advances in directional & orbital atherectomy devices	2.10%	Long term (5+ yrs)	Europe, Asia Pacific (spillover: North America)	Medium	Slow
Rising prevalence of coronary and peripheral artery diseases driving procedural demand	2.20%	High	North America, Europe, Asia Pacific	High	Near Term
Increasing adoption of minimally invasive vascular procedures improving clinical outcomes	1.90%	High	North America, Asia Pacific	High	Mid Term
Expansion of hybrid cath labs enabling advanced image-guided cardiovascular interventions	1.60%	Moderate	Europe, North America	Emerging	Long Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 43.99% share of the atherectomy devices market in 2025, bolstered by broad procedure adoption across established vascular care settings and consistent use of device-based interventions in peripheral and coronary artery disease management. The region’s leadership is sustained by mature hospital and ambulatory cardiovascular networks, higher procedural volumes, and clinician familiarity with atherectomy in complex lesion preparation, particularly where calcification can limit the effectiveness of conventional angioplasty alone. This operating environment supports recurring device demand through routine interventional practice rather than isolated uptake.

Asia Pacific is projected to expand at a 9.15% CAGR over the forecast period, with growth in the atherectomy devices market being propelled by increasing access to interventional vascular treatment and the gradual shift toward more advanced minimally invasive procedures. Adoption is accelerating as providers in major regional healthcare centers broaden their capability to manage complex arterial blockages with specialized devices, while expanding treatment capacity and rising procedural exposure improve comfort with atherectomy-based approaches in daily clinical use.

Regional Market Attractiveness & Strategic Fit Matrix
Parameter	North America	Asia Pacific	Europe	Latin America	MEA
Innovation Hub	Advanced	Developing	Advanced	Developing	Developing
Cost-Sensitive Region	Low	High	Medium	High	High
Regulatory Environment	Supportive	Neutral	Supportive	Neutral	Neutral
Demand Drivers	Strong	Strong	Strong	Moderate	Moderate
Development Stage	Developed	Developing	Developed	Developing	Emerging
Adoption Rate	High	High	High	Medium	Medium
New Entrants / Startups	Moderate	Moderate	Moderate	Sparse	Sparse
Macro Indicators	Strong	Strong	Stable	Stable	Stable

Key Country Insights

United States

Advanced Intervention Adoption

The U.S. atherectomy devices market emphasizes minimally invasive treatment for peripheral and coronary artery disease through technologically advanced plaque removal systems. Healthcare providers in the U.S. continue expanding image-guided procedures and outpatient vascular interventions to improve procedural efficiency.

Japan

Complex Lesion Management

Japan continues adopting atherectomy devices for calcified vascular lesions requiring precise endovascular intervention. Clinicians in Japan emphasize device performance, procedural safety, and compatibility with minimally invasive treatment strategies for aging patient populations.

South Korea

Innovation-Driven Procedures

South Korea strengthens atherectomy adoption through modern catheterization laboratories and increasing demand for minimally invasive vascular care. Healthcare providers in South Korea actively evaluate advanced plaque modification technologies that enhance clinical workflow and patient outcomes.

Germany

Precision Vascular Care

Germany prioritizes atherectomy technologies that integrate with advanced imaging and evidence-based vascular treatment pathways. Hospitals in Germany focus on device reliability and procedural precision while supporting complex peripheral artery disease management.

France

Integrated Vascular Treatment

France supports atherectomy device adoption within multidisciplinary cardiovascular care programs focused on complex arterial disease. French healthcare institutions increasingly incorporate advanced endovascular technologies that improve treatment flexibility and procedural planning.

Italy

Specialized Endovascular Practice

Italy continues expanding the use of atherectomy devices in specialized vascular centers treating peripheral artery disease. Clinical teams in Italy prioritize effective plaque removal technologies that complement balloon angioplasty and other minimally invasive interventions.

Segment Leadership and Growth Trends

  Type Segment Analysis: Directional Atherectomy (Largest Segment) vs Laser Atherectomy (Fastest-Growing Segment)

Directional Atherectomy held a 38.05% share of the atherectomy devices market in 2025, making it the leading type segment. Its position is aided by its practical value in plaque removal where physicians need controlled, targeted excision within complex peripheral lesions. That procedural control fits established treatment workflows and supports continued use in cases where vessel preparation and lumen gain are central clinical objectives, helping Directional Atherectomy retain its leadership in the atherectomy devices market.

Laser Atherectomy is emerging as the fastest-growing segment in the atherectomy devices market as treatment approaches increasingly favor technologies that can address difficult lesion morphology with precision and less dependence on mechanical cutting alone. Its growth momentum is tied to expanding clinical interest in handling challenging calcified, fibrotic, or in-stent lesions where operators seek greater procedural flexibility relative to conventional alternatives. As these requirements become more prominent in endovascular practice, Laser Atherectomy is gaining traction faster than other type segments.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Type	Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy	Directional Atherectomy	Laser Atherectomy

Competitive Landscape and Market Positioning

Leading companies in the atherectomy devices market:

1. Boston Scientific Corporation (United States)

2. Medtronic plc (Ireland)

3. Abbott Laboratories (United States)

4. Koninklijke Philips N.V. (Netherlands)

5. Becton Dickinson and Company (United States)

6. Terumo Corporation (Japan)

7. AngioDynamics Inc. (United States)

8. Cardinal Health Inc. (United States)

9. Avinger Inc. (United States)

The atherectomy devices market is advancing through continuous innovation focused on improving cardiovascular treatment outcomes and procedural precision. Device enhancements are increasingly centered on safety, efficiency, and minimally invasive performance. Strong R&D activity is supporting next-generation device development, while collaborative efforts are helping refine clinical usability and expand therapeutic applications.

Competitive Dynamics and Strategic Insights
Assessment Parameter	Assigned Scale	Scale Justification
Market Concentration	Medium	The market features several key players like Boston Scientific and Medtronic, but there is still room for new entrants.
M&A Activity / Consolidation Trend	Active	Recent acquisitions, such as Medtronic's purchase of Mazor Robotics, indicate a trend towards consolidation in the market.
Degree of Product Differentiation	High	Products vary significantly in technology and application, with innovations like laser and rotational atherectomy devices.
Competitive Advantage Sustainability	Durable	Established brands have strong patents and a loyal customer base, ensuring sustained competitive advantages.
Innovation Intensity	High	Continuous advancements in minimally invasive techniques and technology drive high innovation intensity.
Customer Loyalty / Stickiness	Strong	Healthcare providers tend to remain loyal to established brands due to reliability and proven outcomes.
Vertical Integration Level	Medium	While some companies are vertically integrated, many still rely on third-party suppliers for components.

Industry Development/News

Company Name	Date	Key Development
Abbott	Apr-23	Abbott completed the acquisition of Cardiovascular Systems, Inc., a specialist in atherectomy systems used for peripheral and coronary artery disease treatment. The integration adds orbital atherectomy technology to Abbott’s vascular portfolio, strengthening its minimally invasive intervention capabilities and expanding its offering across vessel preparation solutions used in angioplasty and stenting procedures globally.
Koninklijke Philips N.V.	Dec-21	Koninklijke Philips N.V. acquired Vesper Medical Inc., a U.S.-based developer of minimally invasive peripheral vascular devices. The acquisition enhances Philips’ vascular intervention portfolio by incorporating venous stent technologies targeting deep venous disease, strengthening its position in the broader peripheral vascular and minimally invasive treatment market.
Avinger	Aug-24	Avinger completed the commercial launch of its Pantheris LV image-guided directional atherectomy system for peripheral artery disease treatment in larger vessels, including the superficial femoral artery. The system features enhanced plaque excision speed and improved catheter control, expanding Avinger’s image-guided atherectomy portfolio and reinforcing its competitive positioning in above-the-knee interventions.